FDA chief backs alternate method for injecting Bavarian Nordic's monkeypox shot




  • In US
  • 2022-08-11 16:43:29Z
  • By Reuters
 

(Reuters) - The U.S. Food and Drug Administration chief on Thursday defended a plan to administer Bavarian Nordic's monkeypox shot intradermally after the company raised doubts about the safety of the method, citing a lack of data.

The company had on Tuesday said there was some evidence that a shot of Jynneos between the layers of the skin could result in increased reactions compared to the approved method of injecting it underneath the skin.

FDA chief Robert Califf, however, backed the method saying while the intradermal administration led to some mild-to-moderate side effects, it produced a similar immune response to injecting the vaccine below the skin.

"In authorizing an unapproved use of an already approved product, the FDA is ensuring the vaccine meets high standards for safety, immune response and manufacturing quality," Califf tweeted. (https://bit.ly/3SEedCt)

The U.S. health regulators had on Monday authorized the emergency use of the shot by recommending an alternate method of use, which would result in splitting a single vial of Jynneos into five doses.

"This may have a negative impact on vaccine uptake and coverage," the company had said in a letter to the FDA on Tuesday.

The company is also testing the potency of doses that the government had bought earlier and is stored in the Strategic National Stockpile to see if they can be used to fight the current outbreak.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Arun Koyyur)

COMMENTS

More Related News

FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner.
FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner.

The Food and Drug Administration on Thursday approved the use of Relyvrio to treat amyotrophic lateral sclerosis, more commonly known as ALS.

ALS drug wins FDA approval despite questionable data
ALS drug wins FDA approval despite questionable data
  • World
  • 2022-09-29 20:55:54Z

A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the...

U.S. FDA approves Amylyx ALS drug
U.S. FDA approves Amylyx ALS drug
  • US
  • 2022-09-29 20:45:08Z

The Amylyx drug, to be sold under the brand name Relyvrio, is a combination of the generic compounds sodium phenylbutyrate and taurursodiol. The company...

CDC Director: U.S. adopting PrEP strategy to expand monkeypox vaccine eligibility
CDC Director: U.S. adopting PrEP strategy to expand monkeypox vaccine eligibility
  • US
  • 2022-09-28 16:42:35Z

The United States is expanding eligibility for Bavarian Nordic's Jynneos monkeypox vaccine by moving to a pre-exposure prophylaxis (PrEP) strategy, U.S...

U.S. FDA proposes new rules for packaged foods to qualify as
U.S. FDA proposes new rules for packaged foods to qualify as 'healthy'
  • US
  • 2022-09-28 14:55:41Z

The proposed changes to food labeling come on the day of the first White House summit on hunger, nutrition and health in more than 50 years. Under the new proposal, packaged products will be allowed to carry the "healthy" label subject to them containing a certain amount of food from at least one of the groups, recommended by the current dietary guidelines, with specified limits on saturated fat, sodium and added sugars. More than 80% of the U.S. population has not been eating enough vegetables, fruit and dairy, while consuming unhealthy amounts of added sugars, saturated fat and sodium in their diet, the FDA said.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US